Market Cap 1.35B
Revenue (ttm) 124.46M
Net Income (ttm) -66.07M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -53.09%
Debt to Equity Ratio 0.64
Volume 6,753,900
Avg Vol 4,456,680
Day's Range N/A - N/A
Shares Out 236.85M
Stochastic %K 1%
Beta 0.85
Analysts Strong Sell
Price Target $10.19

Latest News on ARDX

3 Biotech/Healthcare Names Under $10 I Am Buying Now

Feb 21, 2025, 4:21 PM EST - 20 hours ago

3 Biotech/Healthcare Names Under $10 I Am Buying Now

GERN MRNA PSNL TEM


Ardelyx, Inc. (ARDX) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 2:32 PM EST - 1 day ago

Ardelyx, Inc. (ARDX) Q4 2024 Earnings Call Transcript


Ardelyx's Medicare Setback Casts Doubt On Long-Term Viability

Nov 14, 2024, 9:34 AM EST - 3 months ago

Ardelyx's Medicare Setback Casts Doubt On Long-Term Viability


Ardelyx, Inc. (ARDX) Q3 2024 Earnings Call Transcript

Oct 31, 2024, 11:20 PM EDT - 4 months ago

Ardelyx, Inc. (ARDX) Q3 2024 Earnings Call Transcript